ROIV.NASDAQRoivant Sciences LTD

Form 4: Roivant Sciences President Sells Shares

Sentiment:

Insider Transaction (Form 4)

📋All filings for Roivant Sciences LTD
🔒Login to Follow

Mayukh Sukhatme, President & CIO and a Director of Roivant Sciences Ltd., sold 664,826 shares of common stock on August 14, 2026.

Summary

  • Option exercise/conversion: acquired 243,177 Common Shares at $3.85 ($936,231) on August 14, 2026; holds 18,873,916 after (Direct).
  • Open-market sale: disposed of 243,177 Common Shares at $36.23 ($8,810,303) on August 14, 2026; holds 18,630,739 after (Direct).
  • Option exercise/conversion: acquired 284,707 Common Shares at $3.85 ($1,096,122) on August 17, 2026; holds 18,915,446 after (Direct).
  • Open-market sale: disposed of 284,707 Common Shares at $36.25 ($10,320,629) on August 17, 2026; holds 18,630,739 after (Direct).
  • Option exercise/conversion: acquired 105,141 Common Shares at $3.85 ($404,793) on August 18, 2026; holds 18,735,880 after (Direct).
  • Open-market sale: disposed of 105,141 Common Shares at $36.59 ($3,847,109) on August 18, 2026; holds 18,630,739 after (Direct).
  • Option exercise/conversion: acquired 31,801 Common Shares at $3.85 ($122,434) on August 18, 2026; holds 18,662,540 after (Direct).
  • Open-market sale: disposed of 31,801 Common Shares at $37.18 ($1,182,361) on August 18, 2026; holds 18,630,739 after (Direct).
  • Option exercise/conversion: disposed of 243,177 Common Shares on August 14, 2026; holds 13,981,186 after (Direct).
  • Option exercise/conversion: disposed of 284,707 Common Shares on August 17, 2026; holds 13,696,479 after (Direct).
  • Option exercise/conversion: disposed of 136,942 Common Shares on August 18, 2026; holds 13,559,537 after (Direct).

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $24,160,402 of stock on the open market.

Insider Transactions

Mayukh Sukhatme — Director, Officer (President & CIO)

DateTransactionSecuritySharesPriceValueHeld After
2026-08-14Option exercise/conversionCommon Shares243,177$4$936.2K18,873,916
2026-08-14Open-market saleCommon Shares243,177$36$8.8M18,630,739
2026-08-17Option exercise/conversionCommon Shares284,707$4$1.1M18,915,446
2026-08-17Open-market saleCommon Shares284,707$36$10.3M18,630,739
2026-08-18Option exercise/conversionCommon Shares105,141$4$404.8K18,735,880
2026-08-18Open-market saleCommon Shares105,141$37$3.8M18,630,739
2026-08-18Option exercise/conversionCommon Shares31,801$4$122.4K18,662,540
2026-08-18Open-market saleCommon Shares31,801$37$1.2M18,630,739
2026-08-14Option exercise/conversionCommon Shares243,177——13,981,186
2026-08-17Option exercise/conversionCommon Shares284,707——13,696,479
2026-08-18Option exercise/conversionCommon Shares136,942——13,559,537

Key Dates

DateDescription
2026-08-14Option exercise/conversion (243,177 shares)
2026-08-14Open-market sale (243,177 shares)
2026-08-17Option exercise/conversion (284,707 shares)
2026-08-17Open-market sale (284,707 shares)
2026-08-18Option exercise/conversion (105,141 shares)
2026-08-18Open-market sale (105,141 shares)
2026-08-18Option exercise/conversion (31,801 shares)
2026-08-18Open-market sale (31,801 shares)
2026-08-14Option exercise/conversion (243,177 shares)
2026-08-17Option exercise/conversion (284,707 shares)
2026-08-18Option exercise/conversion (136,942 shares)

Keywords

insider transaction, Form 4, ROIV, Roivant Sciences Ltd., bearish, Mayukh Sukhatme

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.